Cellectar Biosciences, Inc. (CLRB) vs Estrella Immunopharma, Inc. (ESLA)

Cellectar Biosciences, Inc. and Estrella Immunopharma, Inc. are both Biotechnology companies. Cellectar Biosciences, Inc. and Estrella Immunopharma, Inc. are of similar size ($20.5M and $19.6M). Across the 7 metrics below, Estrella Immunopharma, Inc. leads on 4 and Cellectar Biosciences, Inc. on 3.

Valuation

Metric CLRB ESLA Biotechnology median
P/E n/m n/m 7.88
P/S n/m n/m 11.47
P/B 0.74 n/m 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA 0.50 n/m 0.74
EV/Sales n/m n/m 10.73
Earnings yield (213.33%) (50.81%) (28.84%)
Free cash flow yield (88.77%) (45.47%) (23.03%)

Profitability

Metric CLRB ESLA Biotechnology median
Gross margin 0.00% — 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (125.99%) 148.05% (57.72%)
Return on assets (88.70%) (416.74%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CLRB ESLA Biotechnology median
Revenue growth (TTM) — — 5.64%
EPS growth (last fiscal year) 80.14% (188.78%) —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CLRB ESLA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 6.66 0.20 4.73
Net debt to EBITDA 0.58 0.11 0.96

Dividend

Metric CLRB ESLA Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric CLRB ESLA Biotechnology median
Market cap 19.61m 20.49m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack